Joël Besse, Senior Partner, Atlas Venture
Lionel Carnot, Bay City Capital
Karl Keegan, Managing Director, Life Science Analyst, Canaccord Adams
Dimitri F. Dimitriou, Chief Executive Officer, DyoDelta Biosciences
Heinrich Christen, Partner, Industry Leader Medtech, Ernst & Young
Carole L. Nuechterlein, Corporate Finance, Head, Venture Invetments, F. Hoffman-La Roche
Dr Peter Reinisch, Partner, Global Life Science Ventures
Andreas Wicki, CEO, HBM Partners
Michèle Ollier, Principal, Index Ventures
Stan Yakatan, Chairman, Katan Associates
Christopher Meyer, Head of Business Development and Strategic Planning, Medtronic Europe
Dr Andreas Baenziger, Partner, MedWork
Reinhold Ambros, Managing Director, Novartis Venture Fund, Novartis International
Anthony Rosenberg, Global Head Business Development & Licensing, Novartis Pharma
John Ayliffe, Chief Executive Officer, Precimed
Stephan Meier, Chief Executive Officier, Swissfirst Asset Management
Yvonne Wegmann, Vice President, Head of Issuers & Investor Relations, SWX Swiss Exchange
Dr Alexandra Goll, General Partner, TVM Capital
Nick Lowcock, Managing Director, Warburg Pincus
Roland Diggelmann, Senior VP Sales and Distribution EMEA, Zimmer